WallStreetZenWallStreetZen

NASDAQ: ORIC
Oric Pharmaceuticals Inc Stock Ownership - Who owns Oric Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Oric Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dominic PiscitelliChief Financial Officer2025-06-12300$10.00
$3.00kSell
Dominic PiscitelliChief Financial Officer2025-06-111,700$10.01
$17.02kSell
Dominic PiscitelliChief Financial Officer2025-06-111,276$10.00
$12.76kSell
Dominic PiscitelliChief Financial Officer2025-06-10324$10.00
$3.24kSell
Dominic PiscitelliChief Financial Officer2025-06-09300$10.00
$3.00kSell
Dominic PiscitelliChief Financial Officer2025-06-062,600$10.01
$26.02kSell
Lori Anne KunkelDirector2025-03-0320,500$6.33
$129.77kBuy
Lori Anne KunkelDirector2025-03-0327,666$3.75
$103.75kBuy
Jacob ChackoPRESIDENT AND CEO2024-12-1624,660$8.28
$204.21kSell
Dominic PiscitelliChief Financial Officer2024-12-168,851$8.28
$73.30kSell

1 of 2

ORIC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORIC insiders and whales buy or sell their stock.

ORIC Shareholders

What type of owners hold Oric Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Investors LP9.25%6,572,700$63.30MInstitution
Blackrock Inc7.65%5,435,087$52.34MInstitution
Pfizer Inc7.56%5,376,344$51.77MInsider
Pfizer Inc7.56%5,376,344$51.77MInstitution
Nextech Invest Ltd7.44%5,285,714$50.90MInstitution
Peter Svennilson6.71%4,768,181$45.92MInsider
Alkeon Capital Management LLC5.63%4,004,096$38.56MInstitution
Column Group II LP5.02%3,568,255$34.36MInsider
Column Group LLC4.98%3,540,777$34.10MInstitution
Ecor1 Capital LLC4.81%3,418,068$32.92MInstitution

1 of 3

ORIC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORIC78.62%21.38%Net SellingNet Selling
ANAB48.46%51.54%Net BuyingNet Buying
AVXL36.80%5.15%Net BuyingNet Buying
ABUS28.66%71.34%Net Selling
DAWN59.49%40.51%Net SellingNet Selling
View Top Biotech Stocks

Oric Pharmaceuticals Stock Ownership FAQ

Who owns Oric Pharmaceuticals?

Oric Pharmaceuticals (NASDAQ: ORIC) is owned by 111.42% institutional shareholders, 30.31% Oric Pharmaceuticals insiders, and 0.00% retail investors. Pfizer Inc is the largest individual Oric Pharmaceuticals shareholder, owning 5.38M shares representing 7.56% of the company. Pfizer Inc's Oric Pharmaceuticals shares are currently valued at $51.77M.

If you're new to stock investing, here's how to buy Oric Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.